Major Driver in Personalized Psychiatry Global Market: Increasing Mental Health Issues Fueling The Growth Of The Market

June 20, 2025 03:29 AM AEST | By EIN Presswire
 Major Driver in Personalized Psychiatry Global Market: Increasing Mental Health Issues Fueling The Growth Of The Market
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034.

In recent years, the personalized psychiatry market size has seen substantial growth and is expected to escalate from $5.69 billion in 2024 to $6.53 billion in 2025 at a compound annual growth rate CAGR of 14.8%. This growth has been consistently fueled by increasing awareness about mental health, the prevalence of psychiatric disorders, and the jostling demand for personalized healthcare. Furthermore, rising healthcare expenditures coupled with increasing healthcare access and affordability have also contributed to this upward trajectory.

What Is The Projected Future Growth Of The Personalized Psychiatry Market Size?
The personalized psychiatry market size is predicted to continue its rapid ascent in the next few years, reaching $11.24 billion in 2029 at a compound annual growth rate CAGR of 14.6%. The projected growth in the forecast period can be attributed to the expanding use of digital therapeutics, burgeoning need for remote patient monitoring, and an increasing demand for mental health solutions post-COVID-19.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=24365&type=smp

What Are The Key Drivers Propelling The Growth Of The Personalized Psychiatry Market?
One of the key drivers steering the growth of the personalized psychiatry market forward is the escalating mental health issues prevalent globally. Mental health issues, which span a wide range of conditions impacting an individual's emotional, psychological, and social well-being, are primarily triggered by rising stress and lifestyle-related challenges, poor work-life balance, and limited coping mechanisms. Personalized psychiatry extends support to mental health issues by offering tailored treatment plans based on individual biological, psychological, and lifestyle factors. By reducing trial and error in treatment, it enhances care effectiveness, leading to faster recovery and improved patient outcomes. A holistic exploration of these growth drivers is available in the full report here: Report Link

What Key Player Strategies Are Driving The Personalized Psychiatry Market?
The key industry players in the personalized psychiatry market include well-established names such as Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb, Medtronic Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, and Neurocrine Biosciences among others. These companies have been actively focusing on advancing services and innovations in the market, lending their heft to the overall market growth.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report

How Is The Personalized Psychiatry Market Segmented?
Segmentation of the personalized psychiatry market, which plays a pivotal role in understanding market trends, encompasses several types, technologies, applications, and end-users. The type of personalized psychiatry can be categorized into products, services, and software. Based on technology, it can be broken down into genetic testing, artificial intelligence, neurostimulation technology, and digital therapeutics. Application-wise, it extends to depression, anxiety disorders, bipolar disorder, schizophrenia, and attention-deficit hyperactivity disorder ADHD. As for the end-users, the market caters to clinics, hospitals, research institutes, and homecare settings.

What Are The Regional Insights In The Personalized Psychiatry Market?
It's noteworthy that North America was the largest region in the personalized psychiatry market in 2024. However, the report covers reflections and insights from other regions as well, including Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Telepsychiatry Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report

AI in Mental Health Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-mental-health-global-market-report

Digital Mental Health Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/digital-mental-health-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.